The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Huge news (IMHO) but as you say flying happily along under the radar.
They really could do with upping their PR game - they've got a lot to talk about!
Also bought in at 0.3p .... but have averaged down to 0.15p.
We have infrastructure ... a crop ...an asset , and a market with 2 signed-up buyers in Germany .... so hopefully we will soon have revenue.
Also talking to other European countries
Still early days, but the potential is huge, and the first crop being harvested will be a major inflection point!
0.16 .....maybe 0.2p
...... 2 Buyers I think
Things hotting up a bit ... Could Zak be onto something?! LOL
Momentum building as the first crop approaches maturity. I hope to see the company ramping up their PR in the next couple of weeks....... Could maybe start by revamping that disgusting purple website! LoL
This slight delay could work to their advantage ... The maiden JORC resource declaration is going to almost coincide with Main Market listing
This looks like a 'Slam-Dunk' IMHO. World class REE project in Mining Friendly Mozambique.
Tiny market cap , tiny free float.
Recent placing oversubscribed
The move to the Main market of LSE will hugely increase interest and liquidity
Maiden JORC and Scoping study to be released in next couple of weeks
Last chance to buy in before what l suspect will be a very significant re-rate!
Surely got to be worth a punt at these levels. Company looking a lot more focused. Cash coming in, I agree with AMS on board that should support a price of 1.5p
Topped up this am ..... but predictably showing as a sell
I am sitting on the sidelines at the moment. MCap of £3m with a JORC resource of $261 is certainly interesting.
BOD has said it will take ~£2m to bring Gravelotte up to scratch .... Does that mean coming to the market for cash?
Must be getting close to the second Smelter coming on line?
Dry Eye Disease is certainly very common, and certainly as a GP I used to see a couple of cases a week.
The science here looks pretty solid, and with clinical trials due to start any day now things are starting to get exciting.
....Still slightly concerned at the horrendous spread this trades on (even though you can generally trade well inside this)
A sniff of positive results here and OKYO will really take off!
LOL, I'm sure you're right! Was just curious. I was hoping that POW might try and take a controlling interest at NBGC.
Which BB was that?
A favourable response to the Pre Sub would be very useful, and hopefully simplify formal FDA approval.
Small MCap with a small Free Float, and Flush with Cash ... There's a lot to like about this company!
*************MarulaMining01 - telegram discussion group
Hoping to get confirmation of first Spodumene delivery this week + update on AIM Listing. Remarkable potential for a company with a MCap of less than £6M
*************MarulaMining01
Very bullish interview on Stockbox. Very undervalued at this price.
https://youtu.be/99v6amqFrs0
I've done all my MARU with H-L on the phone, has been very efficient, but as Flash said the dealing cost is fractionally more (from memory 1% of trade with a max of £20)
No advice intended, but MARUs first Lithium delivery is due in a couple of days and I see that as a major inflection point.
Difficult to understand. Surely FDA approval was what we were waiting for.
Lung Structure AND Function in one non-invasive study. IMHO this will quite quickly become a 'Must-Have' bit of kit. Teaching hospitals will demand it, and Private hospitals will have to get it and the rest will follow.